RVTY

#897
Revvity, Inc.
91.2800 USD
-1.80%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
90.7780
91.6300
Rango anual
83.4800
118.2600
Cambio diario
-1.80%
Variación mensual
+2.50%
Variación en los últimos 6 meses
-3.77%
Cambio anual
-3.77%
Cierres anteriores
92.9500
Abrir
91.1900
Bid
Ask
Mínimo
90.7780
High
91.6300
Volumen
73
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 10.205 B
  • Employee 11 K
  • Founded N/A
  • CEO Prahlad Singh
  • Website www.revvity.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000FXW512
  • Industry Diagnóstico y pruebas
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
46.91
Relación precio/flujo de caja
3.96
Dividendos por acción
0.07
Rendimiento por dividendo, %
0.29

Revvity Inc

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines. In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY.

Noticias